Sensible Biotechnologies

Summer 2021Active

Unlocking the next generation of mRNA medicines

Save

Summer 2021Active

Unlocking the next generation of mRNA medicines

Save

Company details

The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way.

Location

Oxford, England, United Kingdom

Founded

Unknown

Request the Sensible Biotechnologies report.

Sensible Biotechnologies has no report yet. Sign in with your email to request one.